JP2024519529A5 - - Google Patents
Info
- Publication number
- JP2024519529A5 JP2024519529A5 JP2023568007A JP2023568007A JP2024519529A5 JP 2024519529 A5 JP2024519529 A5 JP 2024519529A5 JP 2023568007 A JP2023568007 A JP 2023568007A JP 2023568007 A JP2023568007 A JP 2023568007A JP 2024519529 A5 JP2024519529 A5 JP 2024519529A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- consists solely
- cells
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/ES2021/070316 WO2022234158A1 (es) | 2021-05-06 | 2021-05-06 | Terapia de células t con receptor de antígeno quimérico específico de cd19 |
| ESPCT/ES2021/070316 | 2021-05-06 | ||
| PCT/EP2022/062374 WO2022234134A1 (en) | 2021-05-06 | 2022-05-06 | Cd19-specific chimeric antigen receptor t-cell therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024519529A JP2024519529A (ja) | 2024-05-15 |
| JP2024519529A5 true JP2024519529A5 (https=) | 2025-05-15 |
Family
ID=76355528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023568007A Pending JP2024519529A (ja) | 2021-05-06 | 2022-05-06 | Ｃｄ１９特異的キメラ抗原受容体ｔ細胞療法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240398945A1 (https=) |
| EP (1) | EP4334357A1 (https=) |
| JP (1) | JP2024519529A (https=) |
| AU (1) | AU2022270952A1 (https=) |
| BR (1) | BR112023023061A2 (https=) |
| CA (1) | CA3219214A1 (https=) |
| CL (1) | CL2023003299A1 (https=) |
| CO (1) | CO2023016940A2 (https=) |
| JO (1) | JOP20230269A1 (https=) |
| MX (1) | MX2023013088A (https=) |
| WO (2) | WO2022234158A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025040765A (ja) * | 2023-09-12 | 2025-03-25 | 国立大学法人三重大学 | Ｃａｒをコードする核酸分子とそれを含むベクター、ｃａｒ、ｃａｒを含む免疫細胞とその細胞を含む医薬組成物、細胞傷害活性を向上させる方法、並びにｃａｒを含む免疫細胞の製造方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY35468A (es) * | 2013-03-16 | 2014-10-31 | Novartis Ag | Tratamiento de cáncer utilizando un receptor quimérico de antígeno anti-cd19 |
| FI2997141T3 (fi) * | 2013-05-13 | 2022-12-15 | CD19-spesifinen kimeerinen antigeenireseptori ja sen käyttöjä | |
| KR102136063B1 (ko) * | 2017-12-06 | 2020-07-22 | 앱클론(주) | 악성 b 세포를 특이적으로 인지하는 항체 또는 그의 항원 결합 단편, 이를 포함하는 키메라 항체 수용체 및 이의 용도 |
| WO2019119822A1 (en) * | 2017-12-23 | 2019-06-27 | Uwell Biopharma Inc. | Pharmaceutical chimeric receptor composition and method thereof |
| CN108047332B (zh) * | 2018-01-15 | 2021-08-24 | 阿思科力(苏州)生物科技有限公司 | 以cd19为靶点的特异性抗体、car-nk细胞及其制备和应用 |
| US12331114B2 (en) * | 2018-02-13 | 2025-06-17 | Indian Institute Of Technology Bombay | Humanized anti-CD19 chimeric antigen receptor, its nucleic acid sequence and its preparation |
| WO2020180551A1 (en) * | 2019-03-05 | 2020-09-10 | Promab Biotechnologies, Inc. | Car-t cells with humanized cd19 scfv |
| EP3773918A4 (en) * | 2019-03-05 | 2022-01-05 | Nkarta, Inc. | CD19 DIRECTED CHIMERIC ANTIGEN RECEPTORS AND THEIR USES IN IMMUNOTHERAPY |
-
2021
- 2021-05-06 WO PCT/ES2021/070316 patent/WO2022234158A1/es not_active Ceased
-
2022
- 2022-05-06 US US18/558,895 patent/US20240398945A1/en active Pending
- 2022-05-06 WO PCT/EP2022/062374 patent/WO2022234134A1/en not_active Ceased
- 2022-05-06 MX MX2023013088A patent/MX2023013088A/es unknown
- 2022-05-06 AU AU2022270952A patent/AU2022270952A1/en active Pending
- 2022-05-06 BR BR112023023061A patent/BR112023023061A2/pt unknown
- 2022-05-06 CA CA3219214A patent/CA3219214A1/en active Pending
- 2022-05-06 JP JP2023568007A patent/JP2024519529A/ja active Pending
- 2022-05-06 EP EP22727930.4A patent/EP4334357A1/en active Pending
-
2023
- 2023-10-26 JO JOJO/P/2023/0269A patent/JOP20230269A1/ar unknown
- 2023-11-06 CL CL2023003299A patent/CL2023003299A1/es unknown
- 2023-12-05 CO CONC2023/0016940A patent/CO2023016940A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023113893A5 (https=) | ||
| JP7356970B2 (ja) | 多重特異性抗体とその作製及び使用方法 | |
| JP2022510964A5 (https=) | ||
| JP2021524244A5 (https=) | ||
| JP2019502676A5 (https=) | ||
| JP2020504723A5 (https=) | ||
| JP2020528750A5 (https=) | ||
| JP2021524256A5 (https=) | ||
| JP2021530987A5 (https=) | ||
| CA3054824A1 (en) | Anti-icos agonist antibodies and uses thereof | |
| JP2020501531A5 (https=) | ||
| JP2024105268A (ja) | 多重特異性抗体とその作製及び使用方法 | |
| US11685787B2 (en) | Treatment of cancer with anti-GITR agonist antibodies | |
| JP2018519263A5 (https=) | ||
| JP2012518404A5 (https=) | ||
| WO2021063349A1 (zh) | 靶向bcma的抗体、双特异性抗体及其用途 | |
| CN116199785A (zh) | 多特异性抗体及其制备和使用方法 | |
| JP2025081512A5 (https=) | ||
| JP2021512107A5 (https=) | ||
| AU2024202109A1 (en) | Combinations and uses thereof | |
| JP2025183307A5 (https=) | ||
| JP2024520666A5 (https=) | ||
| JP2023510844A5 (https=) | ||
| JP2021512652A5 (https=) | ||
| JP2025175307A (ja) | 逐次抗ｃｄ１９治療 |